Stefan Slamanig

Amsterdam University of Applied Sciences

Also affiliated with Icahn School of Medicine at Mount Sinai

MedicineAgricultural and Biological SciencesBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate”.

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate

EBioMedicine(2020)10.1016/j.ebiom.2020.103132

N/A

2.7DataRank · unranked

117 citations

Sarah R. Leist, Stephen McCroskery, Yonghong Liu, Stefan Slamanig, Justine Oliva +8 more

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial

EClinicalMedicine(2022)10.1016/j.eclinm.2022.101323

N/A

1.3DataRank · unranked

55 citations

Viravarn Luvira, Saranath Lawpoolsri, Sant Muangnoicharoen, Supitcha Kamolratanakul, Chaisith Sivakorn +42 more

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.07.26.221861

N/A

0.628DataRank · unranked

11 citations

Sarah R. Leist, Stephen McCroskery, Yonghong Liu, Stefan Slamanig, Justine Oliva +8 more

Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial

medRxiv(2021)10.1101/2021.09.17.21263758

N/A

0.486DataRank · unranked

8 citations

Viravarn Luvira, Saranath Lawpoolsri, Sant Muangnoicharoen, Supitcha Kamolratanakul, Chaisith Sivakorn +41 more

An in vitro experimental pipeline to characterize the epitope of a SARS-CoV-2 neutralizing antibody

mBio(2023)10.1128/mbio.02477-23

N/A

0.444DataRank · unranked

8 citations

Luca Brambilla, Daniel C. Adelsberg, Shreyas Kowdle, Christian S. Stevens, Stefan Slamanig +11 more

Antibody responses to SARS-CoV-2 variants LP.8.1, LF.7.1, NB.1.8.1, XFG and BA.3.2 following KP.2 monovalent mRNA vaccination

medRxiv(2025)10.1101/2025.08.24.25333689

N/A

0.292DataRank · unranked

6 citations

Brian Lerman, Jordan Ehrenhaus, Brian Monahan, Gagandeep Singh, Adria Wilson +13 more

Reduced Fc-mediated antibody responses after COVID-19 mRNA vaccination in a cohort of people living with HIV-1

Scientific Reports(2025)10.1038/s41598-025-26149-z

N/A

0.104DataRank · unranked

1 citations

Priyanka Gadam Rao, Juan C. Bandrés, Ismael Pena, Katherine Bolanos Roldan, Gagandeep Singh +8 more

Immunogenicity and efficacy of homologous and heterologous NDV and MVA SARS-CoV-2 vaccines in mice and hamsters

npj Vaccines(2025)10.1038/s41541-025-01299-3

N/A

0DataRank · unranked

0 citations

Kaijun Jiang, Irene González‐Domínguez, Daniel Rodríguez-Martín, Adam Abdeljawad, Anastasija Čupić +11 more

A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.07.30.229120

N/A

0DataRank · unranked

40 citations

Stephen McCroskery, Wen‐Chun Liu, Sarah R. Leist, Yonghong Liu, Randy A. Albrecht +11 more

Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice

Microbiology Spectrum(2022)10.1128/spectrum.01538-22

N/A

0DataRank · unranked

42 citations

José Luis Martínez, Stefan Slamanig, Nicholas Lemus, Yonghong Liu, Tsoi Ying Lai +12 more

Safety and Immunogenicity of An Egg-Based Inactivated Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomized, Placebo-Controlled, Phase 1/2 Trial in Vietnam

medRxiv(2022)10.1101/2022.02.01.22270253

N/A

0DataRank · unranked

3 citations

Vũ Đình Thiểm, Ha Hai Vu, Van Thanh Ta, Anh Thi Van Pham, Mai Thị Ngọc Đặng +28 more

Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.21.485247

N/A

0DataRank · unranked

3 citations

José Luis Martínez, Stefan Slamanig, Nicholas Lemus, Yonghong Liu, Tsoi Ying Lai +11 more

Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice

EBioMedicine(2024)10.1016/j.ebiom.2024.105185

N/A

0DataRank · unranked

18 citations

Irene González‐Domínguez, Lauren A. Chang, Nicholas Lemus, Tsoi Ying Lai, José Luis Martínez +13 more

Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach

npj Vaccines(2024)10.1038/s41541-024-01014-8

N/A

0DataRank · unranked

8 citations

Eduard Puente‐Massaguer, Adam Abdeljawad, Tsoi Ying Lai, Yonghong Liu, Madhumathi Loganathan +10 more